Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Beijing Luzhu Biotech Co Ltd
2480Current price
21 HKD
+0.15 HKD (+0.72%)
Last closed
23.8 HKD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
4 442 820 688 HKD
Yield for 12 month
-38.69 %
1Y
3Y
5Y
10Y
15Y
2480
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis; and K193, a bispecific antibody injection to treat B cell leukemia and lymphoma. The company's pre-clinical-stage product candidates comprise Recombinant Varicella vaccine for the prevention of varicella in children; Recombinant Syncytial Virus (RSV) vaccine for the indication of RSV-induced lower respiratory tract disease; K333, a bispecific antibody injection product for the treatment of myeloid leukemia; and K1932 bispecific antibody to treat lymphoma. The company also offers immunoreagents, such as Group A meningococcal polysaccharide IgG, Group C meningococcal polysaccharide IgG, Group Y meningococcal polysaccharide IgG, Group W135 meningococcal polysaccharide IgG, and haemophilus influenzae Type B polysaccharide IgG antibody detection kits. In addition, it develops meningococcal group A and C polysaccharide conjugate vaccine, meningococcal group A and C and haemophilus influenzae type b conjugate vaccine, group ACYW135 meningococcal polysaccharide vaccine, typhoid polysaccharide vaccine, and tetanus toxoid vaccine. The company was formerly known as Beijing Luzhu Biotech. The company was incorporated in 2001 and is headquartered in Beijing, China. Address: No. 3 Guangtong Street, Beijing, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
232.76 HKDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures 2480
1 year
3 years
5 years
10 years
EBITDA
-299 046 190 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-16.53 %
PEG Ratio
–
Return On Equity TTM
-26.71 %
Wall Street Target Price
232.76 HKD
Revenue TTM
–
Book Value
4.66 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2480
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2480
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2480
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-17.8995
Price Book MRQ
4.7766
Financials 2480
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2480
For 52 weeks
17 HKD
38.2 HKD
50 Day MA
23.38 HKD
Shares Short Prior Month
–
200 Day MA
23.13 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart